AE Wealth Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,801
| Closed | -$118K | – | 1902 |
|
|
2022
Q2 | $118K | Buy |
2,801
+1,229
| +78% | +$51.8K | ﹤0.01% | 1629 |
|
|
2022
Q1 | $107K | Buy |
1,572
+596
| +61% | +$40.6K | ﹤0.01% | 1609 |
|
|
2021
Q4 | $119K | Buy |
976
+172
| +21% | +$21K | ﹤0.01% | 1631 |
|
|
2021
Q3 | $113K | Buy |
804
+100
| +14% | +$14.1K | ﹤0.01% | 1546 |
|
|
2021
Q2 | $194K | Buy |
+704
| New | +$194K | ﹤0.01% | 1499 |
|